Fibroblast Growth Factor-23 Is Not a Single Bystander in Chronic Kidney Disease Mortality

被引：1
|
作者：
Pelletier, Solenne [1 ]
Fouque, Denis [1 ]
机构：
[1] Ctr Hosp Lyon Sud, Dept Nephrol, Pierre Benite, Rhone Alpes, France
来源：
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY | 2018年 / 29卷 / 10期
关键词：
fibroblast growth factor; klotho; cardiovascular events; hemodialysis; survival; KLOTHO;
D O I：
10.1681/ASN.2018060583
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：2601 / 2601
页数：1
相关论文
共 50 条
  • [41] Fibroblast Growth Factor 23 and Risks of Mortality and End-Stage Renal Disease in Patients With Chronic Kidney Disease
    Isakova, Tamara
    Xie, Huiliang
    Yang, Wei
    Xie, Dawei
    Anderson, Amanda Hyre
    Scialla, Julia
    Wahl, Patricia
    Gutierrez, Orlando M.
    Steigerwalt, Susan
    He, Jiang
    Schwartz, Stanley
    Lo, Joan
    Ojo, Akinlolu
    Sondheimer, James
    Hsu, Chi-yuan
    Lash, James
    Leonard, Mary
    Kusek, John W.
    Feldman, Harold I.
    Wolf, Myles
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2011, 305 (23): : 2432 - 2439
  • [42] The role of Fibroblast Growth Factor 23 in chronic kidney disease-mineral and bone disorder
    Diniz, Hugo
    Frazao, Joao M.
    NEFROLOGIA, 2013, 33 (06): : 835 - 844
  • [43] Fibroblast growth factor 23 is elevated before parathyroid hormone and phosphate in chronic kidney disease
    Isakova, Tamara
    Wahl, Patricia
    Vargas, Gabriela S.
    Gutierrez, Orlando M.
    Scialla, Julia
    Xie, Huiliang
    Appleby, Dina
    Nessel, Lisa
    Bellovich, Keith
    Chen, Jing
    Hamm, Lee
    Gadegbeku, Crystal
    Horwitz, Edward
    Townsend, Raymond R.
    Anderson, Cheryl A. M.
    Lash, James P.
    Hsu, Chi-yuan
    Leonard, Mary B.
    Wolf, Myles
    KIDNEY INTERNATIONAL, 2011, 79 (12) : 1370 - 1378
  • [44] Associations of Fibroblast Growth Factor 23 with Markers of Inflammation and Leukocyte Transmigration in Chronic Kidney Disease
    Wallquist, Carin
    Mansouri, Ladan
    Norrback, Mattias
    Hylander, Britta
    Jacobson, Stefan H.
    Larsson, Tobias E.
    Lundahl, Joachim
    NEPHRON, 2018, 138 (04) : 287 - 295
  • [45] Fibroblast growth factor 23 and adverse clinical outcomes in chronic kidney disease
    Isakova, Tamara
    CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION, 2012, 21 (03) : 334 - 340
  • [46] Association between serum fibroblast growth factor-23 concentrations and blood calcium levels in chronic kidney disease cats with upper urolithiasis
    Miyakawa, Hirosumi
    Hsu, Huai-Hsun
    Ogawa, Mizuki
    Akabane, Ryota
    Miyagawa, Yuichi
    Takemura, Naoyuki
    JOURNAL OF FELINE MEDICINE AND SURGERY, 2022, 24 (12) : 1245 - 1252
  • [47] Fibroblast growth factor 23 is associated with fractional excretion of sodium in patients with chronic kidney disease
    Xu, Hong
    Hashem, Ali
    Witasp, Anna
    Mencke, Rik
    Goldsmith, David
    Barany, Peter
    Bruchfeld, Annette
    Wernerson, Annika
    Carrero, Juan-Jesus
    Olauson, Hannes
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2019, 34 (12) : 2051 - 2057
  • [48] Higher fibroblast growth factor-23 increases the risk of all-cause and cardiovascular mortality in the community
    Arnlov, Johan
    Carlsson, Axel C.
    Sundstrom, Johan
    Ingelsson, Erik
    Larsson, Anders
    Lind, Lars
    Larsson, Tobias E.
    KIDNEY INTERNATIONAL, 2013, 83 (01) : 160 - 166
  • [49] Fractional Excretion of Phosphorus Modifies the Association between Fibroblast Growth Factor-23 and Outcomes
    Dominguez, Julie R.
    Shlipak, Michael G.
    Whooley, Mary A.
    Ix, Joachim H.
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2013, 24 (04): : 647 - 654
  • [50] Circulating fibroblast growth factor-23 is associated with vascular dysfunction in the community
    Mirza, Majd A. I.
    Larsson, Anders
    Lind, Lars
    Larsson, Tobias E.
    ATHEROSCLEROSIS, 2009, 205 (02) : 385 - 390
12345